Dengyuemed

التحديثات الأخيرة

Dengyuemed

أضاف مادة جديدة Health
2025-11-21 07:42:44 - ترجمة -

Recombinant Human Albumin Injection (Oryza Sativa): A New Hope for Hypoalbuminemia in Cirrhosis
In the realm of modern medicine, cirrhosis remains a prevalent chronic liver disease, often accompanied by hypoalbuminemia (serum albumin levels ≤30 g/L), leading to complications such as ascites and edema that severely impact patients' quality of life. Traditional treatments rely on albumin derived from human plasma, but supply is limited, and there's a potential risk of blood-borne...

0 التعليقات 0 المشاركات 38 مشاهدة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Dengyuemed

أضاف مادة جديدة Fitness
2025-09-20 08:55:44 - ترجمة -

Blinatumomab (BLINCYTO) Prescribing Information | Hong Kong Dengyue Medicine
BLINCYTO® is the world’s first approved BiTE® immuno-oncology therapy, targeting the CD19 surface antigen on B cells. BiTE® molecules help the immune system detect and target malignant cells by bringing T cells—a type of white blood cell capable of killing cells recognized as threats—into contact with cancer cells. By positioning T cells near cancer cells, they can...

0 التعليقات 0 المشاركات 1482 مشاهدة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!

المزيد من المنشورات

DengYue Medicine (DengYueMed/Hong Kong Dengyue Pharmaceutical Limited), founded in 2019, is located in Hong Kong SAR. DengYue is licensed by the Department of Health of Hong Kong to take photos of pharmaceutical import and export wholesalers, specializing in the import and export of new and specialty drugs as well as isolated drugs in the field of major chronic diseases.